[Alcohol septal ablation for obstructive hypertrophic cardiomopathy]

Area of Science:

• Cardiology
• Interventional Cardiology
• Cardiac Surgery

Background:

• Obstructive hypertrophic cardiomyopathy (oHCM) significantly impacts patient quality of life.
• Surgical myectomy is a traditional treatment, but carries substantial risks.
• Alcohol septal ablation presents a less invasive therapeutic option.

Purpose of the Study:

• To evaluate alcohol septal ablation as an alternative to surgical myectomy for symptomatic oHCM.
• To assess the efficacy and safety of achieving therapeutic infarction in the sub-aortic region.
• To compare outcomes with surgical myectomy.

Main Methods:

• Patient selection criteria include symptomatic resistance to medical therapy and a significant left intraventricular gradient (≥50 mmHg).
• Procedure requires rigorous candidate selection and performance at experienced centers with interventional cardiologists and echocardiographists.
• Contrast echocardiography guides the identification of the target septal artery for occlusion.

Main Results:

• Alcohol septal ablation demonstrates comparable benefits to surgical myectomy regarding functional class, exercise capacity, and gradient reduction.
• The procedure is fast, effective, and safe, with similar short- and mid-term morbidity and mortality rates to surgery.
• Complete atrioventricular block, the main complication, is decreasing with widespread adoption of ultrasound-guided techniques.

Conclusions:

• Alcohol septal ablation is a viable and effective alternative for select patients with obstructive hypertrophic cardiomyopathy.
• The technique offers comparable clinical benefits to surgical myectomy with potentially lower procedural risk.
• Ongoing refinement of techniques, particularly ultrasound guidance, is reducing complication rates.